Stockreport

Akebia and Otsuka tweak design of late-stage vadadustat studies, marketing approval in Japan may be 2021; shares down 2% [Seeking Alpha]

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF Akebia and Otsuka tweak design of late-stage vadadustat studies, marketing approval in Japan may be 2021; shares down 2%In anupdate to investors, Akebia Therapeutics (AK [Read more]